This fact sheet provides an overview of the Ryan White Program, the largest HIV-specific federal grant program in the United States.
Study finds biopharmaceutical innovation is responsible for 35% of the increase in life expectancy from 1990 to 2015
Medicines are responsible for more than a third of the improvement in life expectancy from 1990 to 2015, according to a recent study published in Health Affairs. This underscores the crucial role of biopharmaceutical innovation, as life expectancy increased 3.3 years during that time period.
Proposed change to Medicaid line extension definition ignores importance of critical improvements in treatments
In comments recently submitted to the administration, PhRMA raised concerns with a number of changes included in the Centers for Medicare & Medicaid Services (CMS) Medicaid proposed rule. Today, we’re diving deeper into CMS’s proposal to vastly expand the types of medicines that would fall… Read More »Proposed change to Medicaid line extension definition ignores importance of critical improvements in treatments
This side-by-side comparison examines President Trump’s record and former Vice President Biden’s positions across a wide range of key health issues, including the response to the pandemic, the Affordable Care Act marketplace, Medicaid, Medicare, drug prices, reproductive health, mental health and opioids, immigration and health… Read More »Health Care and the 2020 Presidential Election
Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas
According to a recent IQVIA analysis, commercial health plans have increased patients’ average out-of-pocket costs for brand medicines by over 50% in some therapeutic areas since 2015. Notably, of the seven therapeutic areas that IQVIA analyzed, including anticoagulants, asthma/COPD, depression, diabetes, HIV, multiple sclerosis and… Read More »Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas
This tracker provides up-to-date data on federal Ending the HIV Epidemic (EHE( funding, including an overview of funding mechanisms by year, agency, grant mechanism, and jurisdiction. It will be updated over time.
Earlier this month, the International AIDS Conference – the world’s largest conference on HIV and AIDS – took place on a virtual stage. Over five days, the conference showcased the latest research and analysis by leaders in the HIV sector. On Friday, July 24, 9:00 a.m. -10:00 a.m., the CSIS Global Health… Read More »Online Event: Highlights from the Virtual AIDS 2020 Conference
This updated fact sheet provides the latest data on the global HIV/AIDS epidemic, including impact by region, treatment and prevention efforts, and an overview of the U.S. and global responses to the epidemic.
Health insurance coverage and access to care improve health outcomes, including viral suppression, for people with HIV in the United States. Prior research has demonstrated that implementation of the Affordable Care Act (ACA) in 2014 increased coverage among people with HIV and that certain forms… Read More »Insurance Coverage and Viral Suppression Among People with HIV in the United States, 2015-2018
Quantifying PEPFAR’s Role for Women and Girls: Analysis of Monitoring, Evaluation, and Reporting Indicator Data, 2016-2019
Women and girls represent more than half of all people living with HIV worldwide, and HIV is the leading cause of death among women aged 15-49. This analysis sought to quantify PEPFAR’s role for women and girls in key program areas, analyzing data over time… Read More »Quantifying PEPFAR’s Role for Women and Girls: Analysis of Monitoring, Evaluation, and Reporting Indicator Data, 2016-2019
KFF/UNAIDS Analysis Finds Donor Governments Spent US$7.8 Billion for HIV in 2019, Down Almost $200 Million From the Previous Year
Half of the 14 donor governments analyzed in the study decreased their spending on global HIV efforts from 2018 to 2019; six increased; and one held steady. Donor government funding supports HIV care and treatment, prevention and other services in low- and middle-income countries.
This report from KFF and The Joint United Nations Programme on HIV/AIDS (UNAIDS) finds donor government disbursements to combat HIV in low- and middle-income countries totaled US$7.8 billion in 2019, a reduction from the US$8 Billion in 2018 and nearly the same as the funding… Read More »Donor Government Funding for HIV in Low- and Middle-Income Countries in 2019